These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3301785)

  • 21. Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections.
    Milczewska J; Wołkowicz T; Zacharczuk K; Mierzejewska E; Kwiatkowska M; Walicka-Serzysko K; Sands D
    Pediatr Pulmonol; 2020 Jan; 55(1):161-168. PubMed ID: 31556252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity of colistin in cystic fibrosis patients.
    Bosso JA; Liptak CA; Seilheimer DK; Harrison GM
    DICP; 1991 Nov; 25(11):1168-70. PubMed ID: 1763528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with nebulised colistin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa].
    López-Gil Otero MM; Romero-Ventosa EY; Feijoo-Meléndez D; Casanova-Martínez C; Otero-Millán L; Piñeiro-Corrales G
    Rev Esp Quimioter; 2019 Jun; 32(3):217-223. PubMed ID: 30924621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A ten year review of colomycin.
    Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
    Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
    Valerius NH; Koch C; Høiby N
    Lancet; 1991 Sep; 338(8769):725-6. PubMed ID: 1679870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and future of the aerosoltherapy in the treatment of cystic fibrosis patients infected by Pseudomonas aeruginosa].
    Rognon A; Curti C; Montana M; Terme T; Rathelot P; Vanelle P
    Therapie; 2011; 66(6):481-91. PubMed ID: 22186073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.
    Bisgaard H; Pedersen SS; Nielsen KG; Skov M; Laursen EM; Kronborg G; Reimert CM; Høiby N; Koch C
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1190-6. PubMed ID: 9351621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Assael BM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Conole D; Keating GM
    Drugs; 2014 Mar; 74(3):377-87. PubMed ID: 24510624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S;
    Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of
    Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
    Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.
    Flume PA; VanDevanter DR; Morgan EE; Dudley MN; Loutit JS; Bell SC; Kerem E; Fischer R; Smyth AR; Aaron SD; Conrad D; Geller DE; Elborn JS
    J Cyst Fibros; 2016 Jul; 15(4):495-502. PubMed ID: 26852040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
    Berlana D; Llop JM; Manresa F; Jódar R
    Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: preliminary communication.
    De Boeck K; Smet M; Eggermont E
    Pediatr Pulmonol; 1989; 7(3):171-3. PubMed ID: 2508049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.